BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15955531)

  • 1. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
    Warner DR; Greene RM; Pisano MM
    FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular dynamics of Smad-mediated TGFbeta signaling.
    Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
    J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of CBP/p300 in embryonic orofacial mesenchymal cells.
    Warner DR; Pisano MM; Greene RM
    J Cell Biochem; 2006 Dec; 99(5):1374-9. PubMed ID: 16817232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
    Goumans MJ; Mummery C
    Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
    Hwang SG; Yu SS; Lee SW; Chun JS
    FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2+-mobilization in Human Embryonic Kidney 293 cells.
    Verkaar F; van Rosmalen JW; Smits JF; Blankesteijn WM; Zaman GJ
    Cell Signal; 2009 Jan; 21(1):22-33. PubMed ID: 18929644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment.
    Chakladar A; Dubeykovskiy A; Wojtukiewicz LJ; Pratap J; Lei S; Wang TC
    Biochem Biophys Res Commun; 2005 Oct; 336(1):190-6. PubMed ID: 16139800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling through canonical and non-canonical pathways: recent progress.
    Widelitz R
    Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergence of epidermal growth factor - transforming growth factor beta signaling in embryonic orofacial tissue.
    Bhattacherjee V; Greene RM; Michele Pisano M
    In Vitro Cell Dev Biol Anim; 2003; 39(5-6):257-61. PubMed ID: 12880367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
    Cong F; Schweizer L; Varmus H
    Development; 2004 Oct; 131(20):5103-15. PubMed ID: 15459103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.